Summitplc.com logo
  • Our Company
    • Strategy & Mission
    • Leadership
    • Our Board
    • Partnering Opportunities
    • Out-Licensing Opportunities
    • Contact
  • Our Pipeline
  • Clinical Trials
  • Disease Information
  • Innovation Engine
  • Akeso Partnership
    • Overview
    • Ivonescimab (SMT112) Overview
    • Therapeutic Areas
  • News Center
    • Media Resources
    • Press Releases
  • Investor Center
    • Investor Center
    • Announcements, Financial Reports & Filings
    • Email Alerts
    • Share Price Data
    • Analyst Coverage
    • Corporate Governance
    • Board of Directors Diversity Matrix
    • Shareholder Meetings
    • Summit Presentations
  • Career Opportunities
  • Our Company
    • Strategy & Mission
    • Leadership
    • Our Board
    • Partnering Opportunities
    • Out-Licensing Opportunities
    • Contact
  • Our Pipeline
  • Clinical Trials
  • Disease Information
  • Innovation Engine
  • Akeso Partnership
    • Overview
    • Ivonescimab (SMT112) Overview
    • Therapeutic Areas
  • News Center
    • Media Resources
    • Press Releases
  • Investor Center
    • Investor Center
    • Announcements, Financial Reports & Filings
    • Email Alerts
    • Share Price Data
    • Analyst Coverage
    • Corporate Governance
    • Board of Directors Diversity Matrix
    • Shareholder Meetings
    • Summit Presentations
  • Career Opportunities

Sitemap

  • Home
  • media
  • Disease Information
  • Our Company
    • Strategy & Mission
    • Leadership
    • Our Board
    • Partnering Opportunities
    • Out-Licensing Opportunities
      • C. difficile Infection
      • Enterobacteriaceae
    • Contact
  • Pipeline
  • Clinical Trials
  • Innovation Engine
    • Summit Research
    • Discuva
  • Scientific Literature
    • SMT-738 Publications & Presentations
    • CDI Publications & Presentations
    • Discuva
  • Akeso Partnership
    • Overview
    • SMT112
      • Ivonescimab (SMT112) Overview
      • Therapeutic Areas
      • Tetrabody Technology
  • NSCLC
  • News Center
    • Press Releases
    • Media Resources
  • Investors
    • Investor Center
    • Announcements, Financial Reports & Filings
    • Share Price Data
    • Analyst Coverage
    • Corporate Governance
    • Board of Directors Diversity Matrix
    • Summit Presentations
    • Email Alerts
    • Shareholder Meetings
  • Careers
    • Overview
    • Jobs
    • Benefits
  • Page resources
    • Online Terms of Use
    • Privacy Policy
    • Disclaimer
    • Site Map
  • ABOUT SUMMIT THERAPEUTICS
  • Akeso Partnership
  • Ivonescimab (SMT112) Overview
  • Our Pipeline
  • Media Resources
  • Investor Centre
  • Press Releases
  • Reports & Filings
  • Share Price Data
  • Contact
  • Social Media Platforms
  • Twitter
  • Linkedin
Summit Therapeutics Plc Logo
© 2023 Summit Therapeutics Inc.

Trademarks, registered or otherwise, are the property of their respective owner(s). Website Designed and Developed by Carr Kamasa Design

  • Disclaimer
  • Privacy Policy
  • Online Terms of Use
  • Site Map

Website Cookies

This website uses cookies: Please see our Privacy Policy to understand how we use cookies.